DrugPatentWatch Database Preview
Litigation Details for Shire ViroPharma LLC v. CSL Behring LLC (D. Del. 2017)
» See Plans and Pricing
Shire ViroPharma LLC v. CSL Behring LLC (D. Del. 2017)
| Docket | Start Trial | Date Filed | 2017-04-11 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Mitchell S. Goldberg |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,080,788; 10,201,595 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Shire ViroPharma LLC v. CSL Behring LLC
The biologic drug covered by the patents cited in this case is Start Trial .
Details for Shire ViroPharma LLC v. CSL Behring LLC (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-02-11 | 140 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,616,111 ;10,080,788 ;10,105,423 ;…11 April 2017 1:17-cv-00414-MSG 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| 2019-04-23 | 162 | Notice of Service | Intrinsic Evidence for Identified Terms of U.S. Patent Nos. 10,080,788, 10,105,423, 10,130,690 and 10,201,595 …11 April 2017 1:17-cv-00414-MSG 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2019-06-13 | 190 | Answer to Complaint | First Amended Counterclaims Concerning U.S. Patent Nos. 10,080,788; 10,105,432; 10,130,690; and 10,201,595…11 April 2017 1:17-cv-00414-MSG 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2019-06-20 | 201 | Redacted Document | First Amended Counterclaims Concerning U.S. Patent Nos. 10,080,788; 10,105,432; 10,130,690; and 10,201,595…11 April 2017 1:17-cv-00414-MSG 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2019-08-05 | 216 | Opinion - Memorandum Opinion | that a fourth continuation patent—Patent No. 10,201,595 (the “’595 Patent”)—would issue on February …more claims of Shire’s ’788 Patent, ’423 Patent, ’690 Patent, and ’595 Patent. (Id. ¶¶ 32– 100.) …at least claim 1 of the ’788 Patent, the ’423 Patent, and the ’690 Patent. The PTO then indicated that…¶¶ 14–19.) B. The Patents-in-Suit 1. The ’788 Patent On September 25, 2018…2018, the United States Patent and Trademark Office (“PTO”) issued the ’788 Patent, entitled “C1-INH Compositions | External link to document |
| 2019-11-17 | 237 | Opinion - Memorandum Opinion | additional patents—U.S. Patent Nos. 10,080,788 (the “’788 patent”), 10,105,423 (the “’423 patent”), 10,130690… . . .” (’788 patent, claim 1; ’595 patent, claim 1; ’423 patent, claim 1, ’690 patent, claim 1.) Notably… least claim 1 of the ’788 patent, the ’423 patent, and the ’690 patent. The PTO then indicated that…multiple patents owned by Plaintiff. Plaintiff originally alleged infringement of U.S. Patent No. 9,616,111…,130690 (the “’690 patent”), and 10,201,595 (the “’595” patent)—which share the same specification as | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
